These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

813 related articles for article (PubMed ID: 32330214)

  • 21. Enhanced blood brain barrier permeability and glioblastoma cell targeting via thermoresponsive lipid nanoparticles.
    Rehman M; Madni A; Shi D; Ihsan A; Tahir N; Chang KR; Javed I; Webster TJ
    Nanoscale; 2017 Oct; 9(40):15434-15440. PubMed ID: 28976512
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Gallego L; Ceña V
    Expert Opin Drug Deliv; 2020 Nov; 17(11):1541-1554. PubMed ID: 32791861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solid lipid nanoparticles for potential doxorubicin delivery in glioblastoma treatment: preliminary in vitro studies.
    Battaglia L; Gallarate M; Peira E; Chirio D; Muntoni E; Biasibetti E; Capucchio MT; Valazza A; Panciani PP; Lanotte M; Schiffer D; Annovazzi L; Caldera V; Mellai M; Riganti C
    J Pharm Sci; 2014 Jul; 103(7):2157-2165. PubMed ID: 24824141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma.
    Di Mauro PP; Cascante A; Brugada Vilà P; Gómez-Vallejo V; Llop J; Borrós S
    Int J Pharm; 2018 Dec; 553(1-2):169-185. PubMed ID: 30321641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex.
    Kang T; Jiang M; Jiang D; Feng X; Yao J; Song Q; Chen H; Gao X; Chen J
    Mol Pharm; 2015 Aug; 12(8):2947-61. PubMed ID: 26149889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. VEGF-mediated tight junctions pathological fenestration enhances doxorubicin-loaded glycolipid-like nanoparticles traversing BBB for glioblastoma-targeting therapy.
    Wen L; Tan Y; Dai S; Zhu Y; Meng T; Yang X; Liu Y; Liu X; Yuan H; Hu F
    Drug Deliv; 2017 Nov; 24(1):1843-1855. PubMed ID: 29182025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transferrin Receptor-Targeted PEG-PLA Polymeric Micelles for Chemotherapy Against Glioblastoma Multiforme.
    Sun P; Xiao Y; Di Q; Ma W; Ma X; Wang Q; Chen W
    Int J Nanomedicine; 2020; 15():6673-6688. PubMed ID: 32982226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiopep-2-Functionalized Lipid Cubosomes for Blood-Brain Barrier Crossing and Glioblastoma Treatment.
    Cai X; Refaat A; Gan PY; Fan B; Yu H; Thang SH; Drummond CJ; Voelcker NH; Tran N; Zhai J
    ACS Appl Mater Interfaces; 2024 Mar; 16(10):12161-12174. PubMed ID: 38416873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted Delivery of Functionalized Upconversion Nanoparticles for Externally Triggered Photothermal/Photodynamic Therapies of Brain Glioblastoma.
    Tsai YC; Vijayaraghavan P; Chiang WH; Chen HH; Liu TI; Shen MY; Omoto A; Kamimura M; Soga K; Chiu HC
    Theranostics; 2018; 8(5):1435-1448. PubMed ID: 29507632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted Vascular Drug Delivery in Cerebral Cancer.
    Humle N; Johnsen KB; Arendt GA; Nielsen RP; Moos T; Thomsen LB
    Curr Pharm Des; 2016; 22(35):5487-5504. PubMed ID: 27464719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of Therapies for Glioblastoma (GBM) Using Nanoparticle-based Delivery Systems.
    Wiwatchaitawee K; Quarterman JC; Geary SM; Salem AK
    AAPS PharmSciTech; 2021 Feb; 22(2):71. PubMed ID: 33575970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of enhanced antiglioma efficacy of polysorbate 80-modified paclitaxel-loaded PLGA nanoparticles by focused ultrasound.
    Li Y; Wu M; Zhang N; Tang C; Jiang P; Liu X; Yan F; Zheng H
    J Cell Mol Med; 2018 Sep; 22(9):4171-4182. PubMed ID: 29956460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineered nanoparticles for systemic siRNA delivery to malignant brain tumours.
    Karlsson J; Rui Y; Kozielski KL; Placone AL; Choi O; Tzeng SY; Kim J; Keyes JJ; Bogorad MI; Gabrielson K; Guerrero-Cazares H; Quiñones-Hinojosa A; Searson PC; Green JJ
    Nanoscale; 2019 Nov; 11(42):20045-20057. PubMed ID: 31612183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breaching barriers in glioblastoma. Part II: Targeted drug delivery and lipid nanoparticles.
    Miranda A; Blanco-Prieto MJ; Sousa J; Pais A; Vitorino C
    Int J Pharm; 2017 Oct; 531(1):389-410. PubMed ID: 28801108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy.
    Liu Y; Zou Y; Feng C; Lee A; Yin J; Chung R; Park JB; Rizos H; Tao W; Zheng M; Farokhzad OC; Shi B
    Nano Lett; 2020 Mar; 20(3):1637-1646. PubMed ID: 32013452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.
    Zhao X; Ye Y; Ge S; Sun P; Yu P
    Curr Top Med Chem; 2020; 20(30):2762-2776. PubMed ID: 32851962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted nano-delivery of chemotherapy via intranasal route suppresses in vivo glioblastoma growth and prolongs survival in the intracranial mouse model.
    Sandbhor P; Goda J; Mohanty B; Gera P; Yadav S; Chekuri G; Chaudhari P; Dutt S; Banerjee R
    Drug Deliv Transl Res; 2023 Feb; 13(2):608-626. PubMed ID: 36245060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancing the efficacy of drug-loaded nanocarriers against brain tumors by targeted radiation therapy.
    Baumann BC; Kao GD; Mahmud A; Harada T; Swift J; Chapman C; Xu X; Discher DE; Dorsey JF
    Oncotarget; 2013 Jan; 4(1):64-79. PubMed ID: 23296073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delivering siRNA and Chemotherapeutic Molecules Across BBB and BTB for Intracranial Glioblastoma Therapy.
    Yang ZZ; Gao W; Liu YJ; Pang N; Qi XR
    Mol Pharm; 2017 Apr; 14(4):1012-1022. PubMed ID: 28252970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncoprotein Inhibitor Rigosertib Loaded in ApoE-Targeted Smart Polymersomes Reveals High Safety and Potency against Human Glioblastoma in Mice.
    Qin H; Jiang Y; Zhang J; Deng C; Zhong Z
    Mol Pharm; 2019 Aug; 16(8):3711-3719. PubMed ID: 31299161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.